The Inceptiv data give Medtronic more evidence as it tries to increase sales of a product that drove double-digit growth at ...

The Inceptiv spinal cord stimulation system. [Image courtesy of Medtronic] Medtronic (NYSE: MDT) + today announced 12-month data demonstrating the benefits of its Inceptiv closed-loop spinal cord ...

Multiple FDA-approved SCS systems, such as Nevro’s Senza and HFX iQ, as well as Medtronic’s Vanta, Intellis, and Inceptiv systems are available, each offering different features to cater to individual ...

Therapeutic breakthroughs in neuromodulation merge wearable technologies, deep brain implants, and tailored stimulations ...

The new five-year agreement provides Medtronic with exclusivity in certain spine geographies within ... This potentially enables stem cell stimulation to form new bone through the graft and ...

SAN FRANCISCO—While deep-brain stimulation therapy has been available for people with Parkinson’s disease for decades, Medtronic has now received a European approval for what it describes as ...

“Case outcomes (settlement, plaintiff or defendant ruling) did not statistically vary based on the SCS (spinal cord stimulator) manufacturer type-St. Jude, Boston Scientific Corp., or Medtronic.

Predicting who will transition from acute to chronic pain is the “holy grail” of pain neuroscience. A novel biomarker ...

Medtronic Vietnam and the University Medical Center Ho Chi Minh City (UMC HCMC) have signed their fourth Memorandum of Understanding (MoU) to advance healthcare training and education in Vietnam.

has approved the Inceptiv closed-loop rechargeable spinal cord stimulator (SCS) for the treatment of chronic pain. In December 2023, Medtronic announced that the United States Food and Drug ...